INMD
Price
$14.71
Change
-$0.47 (-3.10%)
Updated
Jul 11, 04:59 PM (EDT)
Capitalization
1.82B
13 days until earnings call
MASS
Price
$6.93
Change
-$0.29 (-4.02%)
Updated
Jul 11, 04:59 PM (EDT)
Capitalization
227.41M
31 days until earnings call
Interact to see
Advertisement

INMD vs MASS

Header iconINMD vs MASS Comparison
Open Charts INMD vs MASSBanner chart's image
InMode
Price$14.71
Change-$0.47 (-3.10%)
Volume$24.57K
Capitalization1.82B
908 Devices
Price$6.93
Change-$0.29 (-4.02%)
Volume$4.73K
Capitalization227.41M
INMD vs MASS Comparison Chart in %
Loading...
INMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MASS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INMD vs. MASS commentary
Jul 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INMD is a Buy and MASS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 12, 2025
Stock price -- (INMD: $15.18 vs. MASS: $6.94)
Brand notoriety: INMD and MASS are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: INMD: 160% vs. MASS: 39%
Market capitalization -- INMD: $1.82B vs. MASS: $227.41M
INMD [@Medical Specialties] is valued at $1.82B. MASS’s [@Medical Specialties] market capitalization is $227.41M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INMD’s FA Score shows that 0 FA rating(s) are green whileMASS’s FA Score has 1 green FA rating(s).

  • INMD’s FA Score: 0 green, 5 red.
  • MASS’s FA Score: 1 green, 4 red.
According to our system of comparison, MASS is a better buy in the long-term than INMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INMD’s TA Score shows that 5 TA indicator(s) are bullish while MASS’s TA Score has 4 bullish TA indicator(s).

  • INMD’s TA Score: 5 bullish, 5 bearish.
  • MASS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both INMD and MASS are a good buy in the short-term.

Price Growth

INMD (@Medical Specialties) experienced а +0.13% price change this week, while MASS (@Medical Specialties) price change was +4.36% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.57%. For the same industry, the average monthly price growth was +0.12%, and the average quarterly price growth was -0.35%.

Reported Earning Dates

INMD is expected to report earnings on Oct 22, 2025.

MASS is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Medical Specialties (+0.57% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INMD($1.82B) has a higher market cap than MASS($227M). MASS YTD gains are higher at: 215.455 vs. INMD (-9.102). INMD has higher annual earnings (EBITDA): 196M vs. MASS (-34.03M). INMD has more cash in the bank: 742M vs. MASS (146M). MASS has less debt than INMD: MASS (5.95M) vs INMD (9.02M). INMD has higher revenues than MASS: INMD (492M) vs MASS (50.2M).
INMDMASSINMD / MASS
Capitalization1.82B227M802%
EBITDA196M-34.03M-576%
Gain YTD-9.102215.455-4%
P/E Ratio9.13N/A-
Revenue492M50.2M980%
Total Cash742M146M508%
Total Debt9.02M5.95M152%
FUNDAMENTALS RATINGS
INMD: Fundamental Ratings
INMD
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
99
SMR RATING
1..100
40
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
77
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INMDMASS
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 1 day ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 10 days ago
77%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 15 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 5 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 1 day ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
INMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MASS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MDNAF0.62N/A
+0.81%
Medicenna Therapeutics Corp.
CMOPF64.37N/A
N/A
Cosmo Pharmaceuticals NV
INEOF0.04N/A
N/A
INEO Tech Corp.
ROHCY12.92-0.03
-0.21%
Rohm Co. Ltd.
SCBFY34.87-0.21
-0.59%
Standard Chartered PLC

INMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, INMD has been loosely correlated with CRL. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if INMD jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INMD
1D Price
Change %
INMD100%
-0.33%
CRL - INMD
45%
Loosely correlated
+2.95%
IDXX - INMD
44%
Loosely correlated
+0.08%
RVTY - INMD
44%
Loosely correlated
+2.27%
MTD - INMD
43%
Loosely correlated
+1.44%
TMCI - INMD
43%
Loosely correlated
-0.16%
More